World Wires · story 23825 · unverified · 1 source(s)

Knight Therapeutics Announces Regulatory Approval of NIKTIMVO® in Brazil

MONTREAL, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. ("Knight") (TSX: GUD), a pan-American (ex-US) pharmaceutical company, announced today

Open in the desk

Coverage

• Knight Therapeutics Announces Regulatory Approval of NIKTIMVO® in Brazil GlobeNewswire: public companies · tier D · clear net · 2026-10-06 11:35 UTC

What this site indexes